1. Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin
   Pengfei Zhou et al, 2016, J. Med. Chem. CrossRef
2. Design and synthesis of (Z/E)-2-phenyl/H-3-styryl-2H-chromene derivatives as antimicrotubule agents
   P Panda et al, 2018, J Chem Sci CrossRef
3. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
   Florian Schmitt et al, 2019, Int J Mol Sci CrossRef
4. Hybrid cis-stilbene Molecules: Novel Anticancer Agents
   Natalia Piekuś-Słomka et al, 2019, IJMS CrossRef
5. The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells
   Jennifer C. Lennon et al, 2014, Biochemical Pharmacology CrossRef
6. Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents
   Nitesh Sanghai et al, 2014, Med. Chem. Commun. CrossRef
7. Preparation of 4,5 disubstituted-2H-1,2,3-triazoles from (Z)-2,3-diaryl substituted acrylonitriles
   Nikhil Reddy Madadi et al, 2014, Tetrahedron Letters CrossRef
8. Facile Synthesis of 5-Substituted 1H-Tetrazoles Catalyzed by Tetrabutylammonium Hydrogen Sulfate in Water
   Zengtao Wang et al, 2015, Bull. Korean Chem. Soc CrossRef
9. Dioxol and dihydrodioxin analogs of 2- and 3-phenylacetonitriles as potent anti-cancer agents with nanomolar activity against a variety of human cancer cells
   Nikhil R. Madadi et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
10. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity
    Alieh Ameri et al, 2016, Arch. Pharm. Chem. Life Sci. CrossRef
11. null
    Nicola Piens et al, 2016 CrossRef
12. Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents
    Peggoty Mutai et al, 2017, Bioorganic & Medicinal Chemistry CrossRef
13. β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells
    Azizah M. Malebari et al, 2017, European Journal of Medicinal Chemistry CrossRef
14. null
    Qingjie Zhao et al, 2017 CrossRef
15. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells
    Azizah M. Malebari et al, 2020, European Journal of Medicinal Chemistry CrossRef
16. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications
    Gökçe Şeker Karatoprak et al, 2020, Molecules CrossRef
17. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents
    Xinfen Zhang et al, 2020, CTMC CrossRef
18. Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
    Raquel Álvarez et al, 2020, European Journal of Medicinal Chemistry CrossRef
19. Kinugasa Reaction for DNA-Encoded β-Lactam Library Synthesis
    Ayun Luo et al, 2022, Org. Lett. CrossRef
20. null
    Alessandra Ammazzalorso et al, 2022 CrossRef
21. The trimethoxyphenyl (TMP) functional group: a versatile pharmacophore
    Mohammad Amin Langarizadeh et al, 2023, Med Chem Res CrossRef